We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$14.7B
AUM Growth
-$6.7B
(-31%)
Cap. Flow
-$8.87B
Cap. Flow
% of AUM
-60.4%
Top 10 Holdings %
Top 10 Hldgs %
30.89%
Holding
537
New
135
Increased
77
Reduced
139
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$73.6M |
| 2 |
Home Depot
HD
|
+$56.9M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$56.8M |
| 4 |
Emerson Electric
EMR
|
+$55.2M |
| 5 |
Dow Inc
DOW
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$378M |
| 2 |
Apple
AAPL
|
+$293M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$281M |
| 4 |
Alibaba
BABA
|
+$218M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.59% |
| 2 | Technology | 1.73% |
| 3 | Utilities | 1.59% |
| 4 | Financials | 1.34% |
| 5 | Industrials | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Taysha Gene Therapies
TSHA
$1.83B
| $1.03M | 0.01% |
1,292,600
| – | – |
|
302
Valero Energy
VLO
$90.7B
| $1.03M | 0.01% |
+7,374
| New | +$991K |
|
303
Principal Financial Group
PFG
$24.4B
| $1.03M | 0.01% |
+13,821
| New | +$1.17M |
|
304
Editas Medicine
EDIT
$432M
| $1.01M | 0.01% |
140,000
| – | – |
|
305
Full Truck Alliance
YMM
$10.1B
| $1.01M | 0.01% |
+133,048
| New | +$1.05M |
|
306
LPL Financial
LPLA
$29.3B
| $998K | 0.01% |
4,930
-3,070
| -38% | -$702K |
|
307
Hartford Financial Services
HIG
$38.7B
| $965K | 0.01% |
+13,848
| New | +$1.03M |
|
308
CALL
Autodesk
ADSK
$54.1B
| $916K | 0.01% |
4,400
-43,500
| -91% | -$8.96M |
|
309
DuPont de Nemours
DD
$19.1B
| $874K | 0.01% |
+9,699
| New | +$885K |
|
310
Genuine Parts
GPC
$18.5B
| $848K | 0.01% |
+5,069
| New | +$854K |
|
311
BioAtla
BCAB
$5.76M
| $784K | 0.01% |
5,852
| – | – |
|
312
Cincinnati Financial
CINF
$26.7B
| $753K | 0.01% |
+6,722
| New | +$765K |
|
313
CALL
Thermo Fisher Scientific
TMO
$222B
| $749K | 0.01% |
1,300
-99,300
| -99% | -$56M |
|
314
Keurig Dr Pepper
KDP
$39.9B
| $749K | 0.01% |
+21,230
| New | +$746K |
|
315
Prime Medicine
PRME
$571M
| $738K | 0.01% |
60,000
| – | – |
|
316
Runway Growth Finance
RWAY
$278M
| $725K | ﹤0.01% |
59,798
-11,100
| -16% | -$139K |
|
317
Omnicom Group
OMC
$23.2B
| $699K | ﹤0.01% |
+7,409
| New | +$656K |
|
|
CYT
318
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $654K | ﹤0.01% |
359,500
| – | – |
|
319
CALL
GE Aerospace
GE
$380B
| $650K | ﹤0.01% |
8,520
-481,194
| -98% | -$32.2M |
|
320
IonQ
IONQ
$17.2B
| $615K | ﹤0.01% |
100,000
| – | – |
|
321
Intercontinental Exchange
ICE
$84.5B
| $609K | ﹤0.01% |
5,835
+835
| +17% | +$87K |
|
|
API
322
Agora
API
$386M
| $606K | ﹤0.01% |
+167,298
| New | +$640K |
|
323
CVS Health
CVS
$122B
| $601K | ﹤0.01% |
+8,092
| New | +$679K |
|
324
ON Semiconductor
ON
$31.1B
| $601K | ﹤0.01% |
7,295
-58,873
| -89% | -$4.47M |
|
325
Lincoln National
LNC
$8.75B
| $600K | ﹤0.01% |
+26,690
| New | +$794K |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Laurion Capital Management held 537 positions worth $14.7B, down 31% from $21.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Laurion Capital Management withdrew a net $8.87B in Q1 2023, closing 111 positions and reducing 139 holdings. Its most notable exit was Amazon, an estimated $378M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 3.4% a quarter earlier, followed by Technology and Utilities.
Against the trend, Laurion Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $72.7M.
- Laurion Capital Management's largest Q1 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 666,036 shares worth $72.7M.
- Laurion Capital Management added most to Altimmune in Q1 2023, an estimated $32.7M increase.
- Laurion Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $65.9M.
- Laurion Capital Management fully exited Amazon in Q1 2023, selling an estimated $378M.
- Laurion Capital Management's ten largest holdings make up 31% of its $14.7B portfolio in Q1 2023.
- Laurion Capital Management opened 135 new positions and closed 111 in Q1 2023.
- Laurion Capital Management's portfolio value fell 31% quarter-over-quarter to $14.7B.
Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.